Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. - Wikidata - awgldk - TriplyDB

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

http://www.wikidata.org/entity/Q33741481

about

Risk factors for etiology and prognosis of mantle cell lymphoma Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update Household endotoxin levels and the risk of non-Hodgkin lymphoma Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1 Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.Common infection-related conditions and risk of lymphoid malignancies in older individuals.Different role of tumor necrosis factor-α polymorphism in non-Hodgkin lymphomas among Caucasian and Asian populations: a meta-analysis GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.Familial predisposition and genetic risk factors for lymphoma.Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.Racial differences in mantle cell lymphoma in the United States.Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations Cancer biomarkers in HIV patients Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups Genetic variation in Th1/Th2 pathway genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma Host genetics in follicular lymphoma Four genetic polymorphisms of lymphotoxin-alpha gene and cancer risk: a systematic review and meta-analysis.A search for overlapping genetic susceptibility loci between non-Hodgkin lymphoma and autoimmune diseases NOD2 polymorphisms associated with cancer risk: a meta-analysis.Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.Polymorphisms of the LTA gene may contribute to the risk of myocardial infarction: a meta-analysis.Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study.A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.LTA + 252A > G polymorphism is associated with risk of nasal NK/T-cell lymphoma in a Chinese population: a case-control study.Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium.Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs

P2860

Q26858960-B1A87B7A-39C0-452E-B4EB-5943F7D7DCFA Q28083556-4A3DDA03-F372-4FBA-833F-5004A8E612BD Q28248768-EBF0E4BC-E5A4-4F61-9BB8-97F7514F4548 Q28386274-24DB6D7C-4CAE-467E-9CF5-10DAA295F36D Q28388876-F8179ACC-BAE4-40BF-8E5D-C95C6FA82FED Q28389884-BB14C831-EF26-4CB4-88D0-97E90769A1E0 Q28393760-7F035B65-4806-4D17-AB59-D7631AE281CF Q28742972-0D2582BC-A47C-45C9-B797-F091F738E8E1 Q31063522-A03EE5E5-3E10-4F00-A8A0-5B419ED88F39 Q33586239-2EBE4F25-7081-4EA1-910F-DC609CD7050E Q33598099-6E5BA60B-CFEE-4452-9551-273E0A19D21A Q33682902-F0FAF328-7687-456F-A36C-ABC959BB8464 Q33755625-C0FA3AB0-BE37-477E-8753-17983A231B37 Q33886166-084E36C9-C51B-422D-83FB-564F2C00B260 Q33931850-91BFB352-F0F1-4397-8631-DE54C60391D1 Q34033939-18B65B7F-1408-4041-933A-CA62DDC4A0BD Q34044984-381A1B5F-57A3-4D41-9BAF-2A5CD265A78D Q34137915-D30CA33E-9D23-44F0-9F8F-E999B6AE43A7 Q34137936-6464B095-F785-45EB-8A8B-DD21EA00AB4F Q34360406-EB65C385-8D78-4184-9318-0C932892CB24 Q34410264-F85C3277-DCB3-499B-A00D-DB0D9A2DBCFC Q34488720-06DD9F9D-565A-46AC-BA74-D3B94A83F1F3 Q34561553-4A0CC599-BFB1-49EE-BCC0-2AC12D82BA45 Q34661370-0F827250-A90F-400E-ADBC-B394B3C999CB Q34679277-685FFD4C-2042-4D1C-B195-5C0C17C1C326 Q34715350-D7B0DBAC-460E-4417-BB64-9532559EE5EA Q34785970-89AB7A7C-9749-4532-B971-233534380AF9 Q34805375-2A0AA251-725D-4AE0-8303-540ADEFACE62 Q35031964-BC6C8AB2-2FE3-43CF-A167-C95B49C09F4E Q35038312-BB13288E-A269-4FD1-87E6-01F231DF787A Q35070335-7C29CF64-1AB1-4248-9A51-64D55C23630E Q35085734-F7D63AAC-4222-468C-B7B9-F18F828DE393 Q35107083-0879E29F-7DF2-40E9-9567-427FD91BA277 Q35112864-87DC3758-1048-45F0-9F55-7C3BB681BFAB Q35124031-F005C809-1303-4344-96E3-6E68D31C341D Q35143628-42F54018-2A0F-4490-B7ED-BACE7F2D7382 Q35660939-C8898513-64F6-4CC3-8F31-A53AA27EC51D Q35673561-C2DB37BD-A3A3-4070-A2F3-4A853A850E62 Q35815614-D7526256-763C-4911-A411-7D9E371284EA Q36003601-DC3FC15D-3F95-4F75-B6E2-3878D0B36EE3

P2860

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

http://www.wikidata.org/entity/Q33741481

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@ast

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@en

type

label

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@ast

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@en

prefLabel

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@ast

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@en

P1433

Q33741481-F7C26126-7F81-4474-B972-0CD89CA47A49

P1476

Q33741481-0E02B622-2FBD-4EA7-B56C-CD79824FC944

P2093

Q33741481-02E2553C-83A9-45D7-8FCF-41DC273DE711

Q33741481-192D1E78-6F95-4EA6-A3C9-0C00E361390F

Q33741481-22BC6BF0-40C8-40A3-9DEB-1E53FBC3E97C

Q33741481-22EC6B22-622E-478A-8A62-62D8F3277BC4

Q33741481-3126A5C6-9BFE-40C8-A51E-8F637F7702BF

Q33741481-441378FD-F807-47F6-89BD-4A8C45B40100

Q33741481-48C28B82-17CF-4070-9AA8-D065578CE2E2

Q33741481-4A749EAE-0B26-49C9-9350-979CBD975B00

Q33741481-50ED5B49-576E-43AE-8E9C-F08E430C3955

Q33741481-62AD59D1-7947-4407-ACEA-55EE6C4BECFA

P2860

Q33741481-041B3753-6769-42B9-99E7-49A8664F47B9

Q33741481-0C74F16B-4BAA-4A66-8A4B-06B117DF6A34

Q33741481-0D0C3EB4-8542-4992-8DF9-02274F29DA6F

Q33741481-1D8C37A7-34BB-4331-87F3-44CE10852859

Q33741481-2548FB66-A7B1-4496-8D2D-7FEBF57B1426

Q33741481-28CA6CDB-E0F3-4D9D-A718-B0D383BC9D83

Q33741481-31E321A2-F78D-4345-93E3-E28EEA080950

Q33741481-346A53EC-95D2-48FE-B0D8-D29BDC349872

Q33741481-375727F9-F6A3-43FF-BD4A-CB454BD696AD

Q33741481-39EBA9AD-2726-4F10-A6D9-2BA455F0A588

P304

Q33741481-8B187DE8-C4E8-4991-8F1A-7AD76AD03D50

P31

Q33741481-1F44D9A0-A8D0-44FA-A10E-3D8C1BCF813C

Q33741481-f6d24c06-2f55-4fc9-9958-70f04aba3328

P356

Q33741481-3CA23535-4430-486E-8E93-736AC7D7D9F8

P407

Q33741481-56987040-66B8-43DB-9440-BD05D97805A2

P433

Q33741481-269318C7-F1EE-40AD-BA0A-77B86E6E3710

P478

Q33741481-B176ECEA-86C9-4556-94A8-A48ED9C6A0B2

P50

Q33741481-07294655-9894-4DD5-85BB-AD758D1DE397

Q33741481-0ADE6B97-9922-4EC6-8C92-2A3562C0DF78

Q33741481-11C5FAE2-CCEF-4B5C-9A75-56B0CB2BE8B9

Q33741481-2FD1B7E9-1CA9-4668-A98F-03A945702D05

Q33741481-48E23BA8-8F5B-469B-8B07-6779FE37DC4A

Q33741481-4EBBA9E8-F9BE-430E-9E26-C035FCB1A823

Q33741481-8B7A9876-6BB0-4716-B002-5A70B2AB1A4F

Q33741481-A60F6355-3C54-4FEE-B67A-B374130DF0BB

Q33741481-AA8F402A-E0A1-4D43-AFFB-370DF55C05A0

Q33741481-D92FCDDB-5F8B-4EE0-8F0C-DF36CDB6F2FC

P577

Q33741481-CBB123E8-E7B1-4A2D-9747-1163594DF962

P5875

Q33741481-0BE74D1D-0FA3-4F9A-AE05-4DDA1539A0FF

P698

Q33741481-41CA437D-985D-4CBC-8F80-FFE097248867

P932

Q33741481-8D7E22C7-E4E9-49BA-84EE-C41060A13099

P356

P1433

American Journal of Epidemiology

P1476

Tumor necrosis factor (TNF) an ...... in the InterLymph Consortium.

@en

P2093

Alex Smith

http://www.w3.org/2001/XMLSchema#string

Ann Maree Hughes

http://www.w3.org/2001/XMLSchema#string

Anne J Novak

http://www.w3.org/2001/XMLSchema#string

Anne Kricker

http://www.w3.org/2001/XMLSchema#string

Anneclaire J De Roos

http://www.w3.org/2001/XMLSchema#string

Christine F Skibola

http://www.w3.org/2001/XMLSchema#string

Danica R Skibola

http://www.w3.org/2001/XMLSchema#string

Eleanor Kane

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Holly

http://www.w3.org/2001/XMLSchema#string

Eve Roman

http://www.w3.org/2001/XMLSchema#string

P2860

Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Genetic susceptibility to lymphoma

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma

Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.

Organochlorines and risk of non-Hodgkin lymphoma.

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

P304

267-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWP383

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Chanock

Nathaniel Rothman

Patricia Hartge

Lenka Foretová

Yolanda Benavente

Alexandra Nieters

Angela Brooks-Wilson

P577

2010-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40846876

http://www.w3.org/2001/XMLSchema#string

P698

20047977

http://www.w3.org/2001/XMLSchema#string

P932

2842204

http://www.w3.org/2001/XMLSchema#string